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ABSTRACT
The mammalian ERCC1-XPF endonuclease has a
suggested role in the repair of DNA double-strand
breaks (DSB) by single-strand annealing (SSA).
Here, we investigated the role of ERCC1 in homo-
logous recombination in mammalian cells, and
confirm a role of ERCC1 in SSA. Interestingly,
we also report an unexpected role for ERCC1 in
gene conversion. This provides support that gene
conversion in mammalian somatic cells is carried
out through synthesis-dependent strand annealing,
rather than through a double Holliday Junction
mechanism. Moreover, we find low frequencies of
SSA and gene conversion in G1-arrested cells,
suggesting that SSA is not a frequent DSB repair
pathway in G1-arrested mammalian cells, even in
the presence of perfect repeats. Furthermore,
we find that SSA is not influenced by inhibition of
CDK2 (using Roscovitine), ATM (using Caffeine
and KU55933), Chk1 (using CEP-3891) or DNA-PK
(using NU7026).
INTRODUCTION
The ERCC1 protein exists in a complex with the XPF
endonuclease, which speciﬁcally cleaves 30 single-stranded
DNA (ssDNA) ﬂaps of double-stranded DNA (dsDNA)
(1). The mammalian ERCC1/XPF endonuclease functions
in nucleotide excision repair (NER) (1,2), gene targeting
(3) and single-strand annealing (SSA) (4). Although
ERCC1 plays a major role in NER, it was found not to
be associated with the defects in any of the known human
NER disorders, such as Xeroderma pigmentosum (XP),
Cockayne syndrome and Trichothiodystrophy (5–7).
However, a human deﬁciency in the ERCC1 gene was
recently reported (8) and the patient’s cells showed only
moderate hypersensitivity to UV light and mitomycin C
as compared to XP patients. Surprisingly, the clinical
features of the ERCC1-defective patient were very
severe and were compatible with a diagnosis of cerebro-
oculo-facio-skeletal syndrome. The mild repair defect
and clinical severity suggest novel functions for ERCC1,
in agreement with the observations in ERCC1 knockout
mice, which display severe phenotypes compared to other
NER deﬁcient mouse models, involving multiorgan
failure, severe runting and death before weaning (9–11).
These observations indicate additional roles for the
ERCC1-XPF endonuclease other than its function
in NER.
There is evidence for a role of ERCC1 in homologous
recombination (HR) between direct repeats in the adenine
phosphoribosyltransferase locus in Chinese hamster cells
(12,13). Moreover, ERCC1/XPF was found to be required
for targeted gene replacement via recombination in mouse
embryonic stem cells (14). SSA is an eﬃcient way to repair
2-ended double-strand breaks (DSB) between repeated
sequences (15). SSA requires resected DNA ends, which
are believed to be produced by the Mre11/Rad50/Nbs1
complex (16). The combined function of the RAD52
protein, which binds 30 ssDNA ends, and the RPA
protein, which binds tightly to ssDNA, is believed to be
suﬃcient to initiate SSA between repeated sequences, e.g.
Alu sequences, in mammalian cells (17–19).
To test the role of ERCC1 in SSA and gene conversion,
we introduced the DRneo recombination reporter
construct into the ERCC1-defective Chinese hamster cell
line UV4, which we then complemented with ERCC1.
A DSB was induced into the reporter construct by trans-
fecting with an I-SceI expression plasmid and SSA
and gene conversion frequencies were determined. We
found reduced levels of both SSA and gene conversion in
ERCC1-defective cells, suggesting that ERCC1 is involved
in both these recombination pathways in mitotic mam-
malian cells. Furthermore, we ﬁnd lower frequencies
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is not a common complement to non-homologous
end joining (NHEJ) in repair of 2-ended DSBs in
G1-arrested cells.
MATERIALS AND METHODS
Celllines
The cell lines used are UV4DR7, ERCC1.17, ERCC1.21
and PEF7. The UV4DR7 cell line was created following
electroporation of the DRneo vector and isolation of
individual clones as described earlier (20). To obtain an
ERCC1-complemented UV4DR7 cell line, the ERCC1
gene was cloned into the PEF6-V5-His-Topo vector
according to the manufacturer’s protocol (Invitrogen).
The ERCC1 cDNA was ampliﬁed in a two-step RT-PCR
with RNA extracted from SPD8 cells using primers;
ERCC1-f 50-CAG ATG GAC CTT GGG AAA GAC-30
and ERCC1-r 50-TTA TGA CGC TGT AGC CTC
AGC-30. A total of 5 10
6 cells/ml were electroporated
with 30mg of pEF6-V5-His-ERCC1 or empty control
vector (1500mF capacity, 250V for 30s). Blasticidin
(5mg/ml) was added 48h following electroporation and
individual blasticidin resistant colonies isolated and
expanded. All cell lines were cultured in Dulbecco’s
Modiﬁed Eagle’s Medium supplemented with 10% fetal
calf serum, penicillin (60mg/ml), streptomycin (100mg/ml)
at 378C containing 5% CO2, in a humidiﬁed incubator.
The medium was supplemented with hygromycin
(0.05mM) in order to maintain the DRneo vector, and
Blasticidin (3mg/ml) to maintain the PEf6-V5-His-ERCC1
and PEF6-V5-His-Topo vector-containing cell lines.
Southern blotting
Genomic DNA was isolated from the UV4DR7 cell line,
phenol–chloroform treated and digested with restriction
endonucleases. Ten microgram of puriﬁed DNA was
digested HindIII, HindIII + SacI, HindIII + KpnI and/or
HindIII + NcoI was used. To determine that only one
integrated copy of DRneo was present in the genome.
The HindIII + XhoI was used to determine the size of
the DRneo substrate in G418
R clones. All DNA was
separated by gel electrophoresis and Southern blotting
was carried out as previously described using the S2neo
fragment as probe (20).
UV survival assay
Five hundred cells from each cell line were seeded over
night to be treated with diﬀerent doses of UV (0, 0.2, 0.5,
1, 2, 5 and 10J/m
2) on the following day. After that they
were incubated for 7–14 days in a humidiﬁed 5% CO2/37C
incubator and then the colonies were ﬁxed and stained
with 0.4% methylene blue in methanol and individual
colonies (greater than 30 cells) counted.
Recombination assay
To avoid contamination with spontaneous G418 resistant
clones in the DRneo recombination assay, 10
3 cells from
each cell lines were separately expanded to conﬂuencency
on about 10 diﬀerent Petri dishes for each cell line
(Ø 100mm). The spontaneous recombination frequency
was determined for each cell population by selection of
2 10
5 cells/plate (Ø 100mm) seeded in G418 (100mg/ml).
Only those cell populations that did not retrieve viable
G418
R colonies were used for further recombination
assays, as they have low background frequency of
spontaneous G418
R cells.
In the recombination assay, 1.5 10
6 cells of each
cell line (UV4DR7, ERCC1.17, ERCC1.21 and PEF7)
were seeded over night, and transiently trans-
fected with or without pCMV3xnls-I-SceI expression
vector (100ng) according to manufacturer’s protocol
(Lipofectamine2000
TM, Invitrogen, UK, ﬁnal DNA con-
centration 10mg/ml) to create DSBs. After 5h of incuba-
tion in the humidiﬁed 5% CO2/378C incubator, cells were
changed to complete medium. Twenty-four hours after
transfection, the cells were trypsinized and counted. For
recombination frequency, 2 10
5 cells/plate (Ø 100mm)
were seeded and G418 (100mg/ml) and/or hygromycin
(0.5mg/ml) were added for selection to both treated and
untreated plates. A total of 500 cells/plate were seeded
to determine the cloning eﬃciency. Plates were incubated
for 7 or 10 days for cloning and selection, respectively,
after which they were ﬁxed and stained with 0.4%
methylene blue in methanol.
For synchronization of cells in G1 phase of the cell
cycle, we plated 1.5 10
6 ERCC1.17 and 2.5 10
6
UV4DR7 cells for 48h to reach contact inhibition,
or 2 10
6 ERCC1.17 and UV4DR7 cells were grown for
48h in serum-free media. Cells were then transiently
transfected with either pCMV3xnls-I-SceI or pEGFP-C2
vectors and then followed the above protocol for cloning
and selection, or treated with inhibitors throughout
the transfection with 2mM caﬀeine, 10mM KU55933,
10mM NU7026, 25mM Roscovitine or 500nM CEP-3891.
All experiments were repeated independently at least
three times.
FACS analysis
To determine lipofectamin transfection rates, cells were
transiently transfected with a reporter vector, pEGFP-C2
Vector (Invitrogen), using the manufacturer’s
protocol (Invitrogen) and expression of EGFP was
analysed by FACS Sort Vantage (Becton Dickinson, UK).
For cell cycle analysis, arrested cells were harvested,
washed twice in PBS and ﬁxed in 70% cold ethanol
followed by treatment with 1mg/ml RnaseA and staining
with 100mg/ml propidium iodide. The proportion of
arrested cells in each phase of cell cycle was then
determined by FACS Sort Vantage.
Western blotting
A total of 2 10
6 cells was plated onto 100mm dishes
and grown for 24h. Cells were then lysed in RIPA
buﬀer (1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS
and 0.1mM PMSF in PBS) in the presence of 1  protease
and phosphatase inhibitor cocktails (Sigma, UK).
An aliquot of 50mg total protein was then run on a 10%
SDS–PAGE gel and transferred to Hybond C membrane
2 Nucleic Acids Research,2008, Vol. 36,No. 1(Amersham Pharmacia, UK) using a semi-dry transfer cell
(Bio-Rad). This membrane was blocked in 5% milk for 1h
and immunoblotted with mouse monoclonal antibody
ERCC1 vAb-2 (clone 8F1; Labvision), diluted 1:200 in
5% milk in PBS-0.05% Tween and rabbit anti-actin
(Sigma) antibody diluted 1:2000 in 5% milk in PBS-0.05%
Tween overnight. Anti-mouse peroxidase conjugate
(Sigma 1:2000) and anti-rabbit peroxidase conjugate
(Cell Signaling 1:1000) were used, respectively, as second-
ary antibodies and immunoreactive protein was visualized
using ECL reagents (Amersham Pharmacia) following
manufacturer’s instructions.
RESULTS
ERCC1 is involvedin SSA andgene conversion
Here, we studied the role of ERCC1 using a recombina-
tion reporter construct, DRneo (21), which contains
a hygromycin (Hyg) resistance gene and two non-
functional copies of the neo
R gene. After introduction of
a DSB, these non-functional copies revert to a functional
neo
R gene through either SSA, sister chromatid exchange
(SCE) or gene conversion, conferring resistance to
geneticin (G418) (Figure 1A). We ﬁrst stably integrated
the DRneo reporter construct into the genome of the UV4
hamster cell line that is deﬁcient in ERCC1 (1), and
isolated individual hygromycin-resistant clones. The pre-
sence and correct integration of a single DRneo copy into
the UV4DR7 clone was conﬁrmed using Southern blotting
with S2neo as probe (Figure 1B). HindIII cleavage
resulted in a single 6.5kb band, showing that the DRneo
construct is present in one copy (Figure 1B). HindIII and
KpnI or SacI cleavage gave the same 6.5kb band, which
implies that KpnI and SacI cleave outside the 6.5kb
region. HindIII and NcoI cleavage produced a 4.7kb and
a 1.4kb band, showing that the internal structure of
DRneo is preserved in the UV4DR7 clone.
The pCMV3xnlsI-SceI vector was transiently trans-
fected into UV4DR7 cells to express the I-SceI endo-
nuclease to induce a DSB in the DRneo substrate. We
performed a ﬂuctuation assay to determine the extent of
recombination induced and found that a DSB induces HR
10
3-fold (Figure 1C). This shows that ERCC1-defective
cells have no overall defect in HR.
We transfected the UV4DR7 cell line with the
pEF6-V5-His vector containing the hamster ERCC1
gene, or with the empty control vector. Individual clones
were isolated and the level of ERCC1 expression quanti-
ﬁed by western blotting, using extracts from hamster
AA8 and human HeLa cells as control (Figure 2A).
The ERCC1.17 and ERCC1.21 clones expressed ERCC1
to the same extent as wild-type hamster AA8 cells and
fully complemented the sensitivity of ERCC1-defective
cells to UV treatments (Figure 2B). In contrast, the clone
PEF7 containing the empty control vector was still
sensitive to UV as a result of the continued defect in
ERCC1. The reason for the slight UV sensitivity diﬀerence
to UV4DR7 is likely explained by that PEF7 the fact is an
isolated clone from UV4DR7.
We investigated HR in the UV4DR7, ERCC1.17,
ERCC1.21 and PEF.7 cell lines by transiently transfecting
the cells with pCMV3xnlsI-SceI vector to create a DSB
in the S2neo fragment of the DRneo reporter construct.
Recombination of DRneo to a neo
R gene can occur
through either gene conversion, SSA or SCE (Figure 1A).
If the neo
R gene is restored by gene conversion, the hyg
R
gene in between the repeats will be retained, while it will
be lost following SSA or SCE (Figure 1A). We selected
recombinant clones with G418 or G418 plus hygromycin
(G418 + Hyg) to determine the frequency of the diﬀerent
recombination events.
If ERCC1 is exclusively involved in SSA, it would be
expected that the levels of G418 resistant, but not G418 +
Hyg resistant, clones would be lower in UV4DR7 and
PEF7 cells, as those represent the products of SSA.
Surprisingly, both the levels of G418 and G418 + Hyg
resistant recombinants were reduced in UV4DR7 and
PEF7 cells (Figure 2C). The levels of SSA and gene
conversion were reduced by 83% and 75% in ERCC1-
defective cells, respectively. These data demonstrate that
ERCC1 is involved not only in SSA, but also in gene
conversion.
We isolated 10 G418-resistant clones and determined
the recombination products using Southern blotting and
compared the results to their subsequent resistance to
hygromycin (Figure 2D). The presence of a 4.0kb band
in the Southern blots correlated with hygromycin resis-
tance. Interestingly, we found a clone with both the
1.1 and 4.0kb bands, indicating that two DRneo alleles
(present after replication) reverted to neo
R genes using
diﬀerent mechanisms, which has been reported earlier for
a similar recombination substrate (20,22). Altogether,
these data show that G418 + Hyg resistance correlates
with a gene conversion recombination product, which
has also been shown to be the case with the same recom-
bination reported earlier (21).
SuppressedSSA in G1-arrested cells
It is well established that HR predominates during and
following replication and that NHEJ predominates in the
G1 phase of the cell cycle (23,24). As SSA is generally
believed to occur also in the absence of a sister chromatid,
it is plausible that this could be a frequently used pathway
for DSB repair in G1-arrested cells, as a complement
to NHEJ. We had the DRneo substrate present in both
ERCC1-defective and complemented cells, allowing us
to test if SSA is speciﬁcally used for DSB repair in
G1-arrested cells. We synchronized cells in the G1 phase
using either serum starvation (SFM) or contact inhibition
(CI) (by growing cells to conﬂuency). We found that a
48-h SFM or CI of UV4DR7 or ERCC1.17 cells
accumulated in the G1 phase (Figure 3A). The cells were
subsequently transfected with the pCMV3xnlsI-SceI
vector for 5h and kept arrested for an additional 19h,
to ensure expression of the I-SceI restriction endonuclease
and DSB formation while cells were still in the G1 phase,
before replating for selection in G418 or G418 + Hyg.
We have previously reported diﬀerential transfection
eﬃciency between cycling and arrested cells (24).
Nucleic Acids Research, 2008, Vol. 36, No. 1 3Thus, to compensate for diﬀerential eﬀects in expression
from the pCMV3xnlsI-SceI, we co-transfected cells with
the same amount of pEGFP-C2 vector, expressing the
green ﬂuorescent protein (GFP) from the same CMV
promoter as the one expressed in the pCMV3xnlsI-SceI
vector. We found reduced GFP expression in G1-arrested
cells (data not shown), in agreement with the previously
published results (24). We determined the I-SceI-induced
recombination frequencies in G1-arrested and cycling cells
and compensated the recombination frequency of the
arrested cells for the reduced transfection eﬃciency.
In ERCC1 expressing wild-type cells, we found that
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Figure 1. Homologous recombination is induced >100-fold by a single DSB in ERCC1-defective UV4DR7 cells. (A) Structure of the DRneo
recombination substrate containing two non-functional copies of the neo
R gene. A functional neo
R gene can be produced by SSA, SCE or gene
conversion upon induction of a DSB following expression of the I-SceI restriction endonuclease. Recombination to a functional neo
R gene using SSA
or SCE results in loss of the hyg
R gene, while the hyg
R gene is preserved following recombination using gene conversion. (B) Southern blot analysis
performed on UV4DR7 to conﬁrm the intact DRneo structure in the cell line. The S2neo was used as probe. (C) Recombination frequency in
UV4DR7 cells following induction of a DSB using transient transfection with the pCMV3nlsI-SceI vector. The average and standard deviation of at
least three experiments is depicted.
4 Nucleic Acids Research,2008, Vol. 36,No. 1both the levels of gene conversion and SSA drop in
G1-arrested cells. The gene conversion level (represented
by the yellow bar) dropped 2-and 4-fold in serum-starved
ERCC1.17 and ERCC1.21 cells, respectively and 3-fold in
both cell lines that were contact-inhibited (Figure 3B),
in agreement with our earlier report that gene conversion
events are reduced in G1-arrested cells (24).
Interestingly, the SSA levels in ERCC1 proﬁcient cells
(represented by blue bar minus yellow bar) dropped 5- to
6-fold in both serum-starved and contact-inhibited cells as
compared to dividing control cells (statistically signiﬁcant
P<0.001). Thus, the eﬃciency of SSA, even within perfect
repeats, is reduced in G1-arrested cells.
The reduction of gene conversion and SSA was not as
profound in ERCC1-defective UV4DR7 and PEF7 cells.
These data suggest that ERCC1-dependent SSA and gene
conversion are more eﬃcient in cycling cells and that
ERCC1-independent recombination events contribute to
the recombination events that restore a functional neo
R
gene in G1-arrested cells. Overall, our data suggest that
ERCC1-dependent SSA and gene conversion is more
eﬃcient following replication in the S/G2 phase of the
cell cycle.
SSAis independent of cell cycle checkpoint signalling
It was reported earlier that HR repair of a DSB depends
on the checkpoint proteins Ataxia-Telangiectasia and
Rad3-related (ATR) and Chk1 (25), and that resection
of DNA ends to facilitate ATR activation and HR relies
on cyclin-dependent kinases (CDK) activity (26–28).
Thus, one reason for reduced SSA in G1-arrested cells
could be the absence of CDK activity in these cells and
thus a reduced resection at DSBs. Absence of resection is
likely to prevent SSA as no ssDNA homologies would be
unveiled. To test the possibility that SSA depends on cell
cycle checkpoint signalling, we used various protein kinase
inhibitors; Roscovitine inhibits CDK especially CDK2,
which plays an essential role in initiating replication (29).
Caﬀeine is a broad range phosphoinositide 3-kinase
related kinase inhibitor, inhibiting both ATM (Ataxia-
Telangiectasia Mutated) and ATR (30). KU55933 is a
speciﬁc ATM inhibitor and NU7026 inhibits the DNA-
dependent protein kinase (DNA-PK) required for NHEJ
(31). CEP-3891 is a speciﬁc inhibitor of Chk1 (25).
We treated ERCC1.17 cells with the inhibitors during
transfection of the pCMV3xnlsI-SceI vector and during
the 24h recovery period before re-plating with selection
with G418 or G418 + Hyg. We found no diﬀerences
in either gene conversion or SSA levels in the presence of
any of the inhibitors (Figure 4). No diﬀerences in gene
conversion or SSA levels were found in the UV4DR7 cell
line (data not shown). Others and we have previously
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Figure 2. ERCC1 is involved in SSA and gene conversion. (A) Western
blot analysis showing the expression of ERCC1 protein in individual
blasticidin resistant UV4DR7 clones transfected with pEF6-V5-His-
ERCC1 vector using a monoclonal ERCC1 antibody and anti-b-actin
antibody as a loading control. (B) Surviving fraction of wild-type AA8,
UV4DR7, PEF7 and ERCC1-complemented UV4DR7 clones
ERCC1.17 and ERCC1.21 following exposure to UV light. The
average (symbol) and standard deviation (bars) of at least three
experiments is depicted. (C) Recombination frequency to G418
or G418 + Hygromycin (Hyg) resistance following transient transfec-
tion of the pCMVI-SceI3xnls vector. The level of resistance to G418
alone reﬂects a recombination event using either gene conversion or
SSA (blue), while frequencies of gene conversion alone are indicated by
G418 + Hyg resistance (yellow). The average and standard deviation
of at least three experiments is depicted. (D) Southern blot analysis
using S2neo as probe on XhoI and HindIII digested DNA isolated
from individual recombinant G418
R clones. The subsequently found
resistance to Hygromycin is indicated.
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Figure 3. SSA is suppressed in the G1 phase of the cell cycle. (A) Cell cycle proﬁles of ERCC1.17 and UV4DR7 cells arrested in the G1 phase by SFM or CI. After 48h arrest, cells were
transfected with either pCMV3xnlsI-SceI or pEGFP-C2 vector for 5h and then maintained arrested for an additional 19h before the recombination or GFP expression assays were performed.
(B) Homologous recombination induced by an I-SceI-induced DSB in the DRneo construct in asynchronous and G1-arrested cells. The average and standard deviation of at least three
experiments is depicted. All values have been corrected for reduced GFP expression in arrested cells. Blue bars indicate gene conversion + SSA (resistance to G418 alone) and yellow bars gene
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1reported that HR is indeed inhibited by caﬀeine, KU55933
and CEP-3891 (25,32,33), using other recombination
reporter substrates. The diﬀerence in these reporter sub-
strates is that they require strand invasion to recover
a neo
R gene, and thus SSA does not produce a neo
R gene.
Overall, our data does not support a role for checkpoint
signalling in SSA.
DISCUSSION
Here, we investigate the role of ERCC1 in HR using
established ERCC1-defective hamster cells (1,34). The
ERCC1 protein partners with the XPF endonuclease, and
together they act as a heterodimer (35,36). Thus, we are
essentially studying the role of the ERCC1/XPF endo-
nuclease in HR. However, it is important to point out
that disease connected with an ERCC1 mutation is much
more severe than those with XPF mutation (8). Thus, the
eﬀects seen here might also be unrelated to XPF. Previ-
ously, it was established that ERCC1 has an important
role in SSA, interstrand cross-link repair as well as in
gene targeting (3,12,37–40). Here, we conﬁrm the role of
ERCC1 in SSA and ﬁnd almost 10-fold reduced levels
of SSA in ERCC1-defective cells.
In spite of the SSA defect in ERCC1-defective cells, it is
important to note that our results show that HR between
repeated sequences is induced >100-fold by a DSB even in
absence of ERCC1 (Figure 1C). Thus, there are likely
other endonucleases that can compensate for the loss of
ERCC1. The recombination reporter used here cannot
distinguish between an SSA and SCE event. However,
it has been shown earlier that SCEs are very rare products
of the repair of 2-ended DSBs produced by I-SceI (20–22).
Thus, the 10-fold reduction in recombination rates likely
corresponds to a defect in SSA.
Interestingly, we also ﬁnd a defect in gene conversion
in ERCC1-defective cells. This implicates a role for the
ERCC1/XPF endonuclease in gene conversion repair of
a 2-ended DSB. Currently, there are two diﬀerent models
suggested for repair of a 2-ended DSB, the double-
Holliday Junction (HJ) model (41) and the synthesis-
dependent strand annealing (SDSA) model (42). The
strand invasion in the SDSA model is reversed, once
repair synthesis has progressed beyond the initial break-
point and the repair is carried out in an SSA step
(Figure 5). As the ERCC1/XPF endonuclease is required
for eﬃcient SSA, it is expected that the same complex also
would carry out cleavage of non-homologous 30 ends
produced also in this model. Thus, our data support the
SDSA model for repair of 2-ended DSBs in favour of
the double-HJ model as the ERCC1/XPF is likely not
a HJ resolvase (43,44). A D-loop nicking model for DSB
repair has recently been proposed for meiotic recombina-
tion (45). The ERCC1/XPF complex may be an important
mediator at several steps in such a pathway (Figure 5),
but it is unexplored whether this pathway would be
applicable for 2-ended DSB repair in mitosis.
It has been argued that SSA, as opposed to homologous
recombination, is independent of the cell cycle stage
as only a single DNA molecule is used and the sister
chromatid is expendable. Here, we ﬁnd that the level of
SSA is reduced 3-fold in G1-arrested cells, which does not
support a role for SSA in the G1 phase of the cell cycle.
We ﬁnd a 3-fold reduction in SSA in spite of the fact that
perfect repeat sequences are available for repair. There are
only limited repeat sequences present in mammalian cells
(46) and thus the actual SSA levels in G1-arrested cells are
probably even lower than we report here.
Here, we wanted to determine what could be respon-
sible for the suppression of SSA in the G1 phase of the cell
cycle. It has been reported earlier that resection at a DSB
depends on CDK activity (26–28) and that HR depends
on ATM (47) and Chk1 signalling (25). Resection at
a DNA end is required for SSA and thus we wanted to
test if SSA depends on any of the CDK2, ATM, Chk1
or DNA-PK kinases. Although all inhibitors were used
at concentrations that inhibit these enzymes in the
same cell type (25,31), we found no eﬀect on the levels
of SSA. Overall, this suggests that CDK2, ATM, Chk1 or
DNA-PK are not involved in SSA or alternatively that the
single DSB produced by the I-SceI endonuclease is not
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Figure 4. SSA of a single DSB is independent of inhibition of ATM,
DNA-PK, CDK and Chk1 activity. Homologous recombination
induced by an I-SceI-induced DSB in the DRneo construct in the
ERCC1.17 cell line, co-treated with 2mM caﬀeine, 10mM KU55933,
10mM NU7026, 25mM Roscovitine or 500nM CEP-3891 throughout
transfections and 24h recovery period prior to the recombination
assay, using selection with (A) G418 alone (gene conversion + SSA) or
(B) G418+Hyg (gene conversion only). The average and standard
deviation of at least three experiments is depicted.
Nucleic Acids Research, 2008, Vol. 36, No. 1 7suﬃcient to trigger a checkpoint response that activates
DNA damage signalling.
In conclusion, we show that the ERCC1/XPF endo-
nuclease is involved in both SSA and gene conversion in
mammalian cells, which favours the SDSA model for
repair of 2-ended DSBs. We ﬁnd that SSA is suppressed
in the G1 phase of the cell cycle and that SSA of a single
DSB occurs eﬃciently also in presence of inhibitors of cell
cycle checkpoints and DNA repair.
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